In a filing, Tempest Therapeutics Inc revealed its Owner Versant Venture Capital VI, L. acquired Company’s shares for reported $0.43 million on Aug 12 ’24. In the deal valued at $1.10 per share,387,999 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Versant Venture Capital VI, L. sold 400,000 shares, generating $540,040 in total proceeds. Upon selling the shares at $1.35, the 10% Owner now owns 597,940 shares.
Before that, Versant Venture Capital VI, L. sold 387,999 shares. Tempest Therapeutics Inc shares valued at $426,993 were divested by the 10% Owner at a price of $1.10 per share. As a result of the transaction, Versant Venture Capital VI, L. now holds 209,941 shares, worth roughly $0.18 million.
Scotiabank initiated its Tempest Therapeutics Inc [TPST] rating to a Sector outperform in a research note published on March 14, 2024; the price target was $13. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating.
Price Performance Review of TPST
On Monday, Tempest Therapeutics Inc [NASDAQ:TPST] saw its stock fall -4.72% to $0.85. Over the last five days, the stock has lost -22.92%. Tempest Therapeutics Inc shares have fallen nearly -80.73% since the year began. Nevertheless, the stocks have fallen -74.23% over the past one year. While a 52-week high of $6.00 was reached on 04/02/24, a 52-week low of $0.83 was recorded on 11/18/24. SMA at 50 days reached $1.1811, while 200 days put it at $2.4584.
Levels Of Support And Resistance For TPST Stock
The 24-hour chart illustrates a support level at 0.8053, which if violated will result in even more drops to 0.7626. On the upside, there is a resistance level at 0.8853. A further resistance level may holdings at 0.9226. The Relative Strength Index (RSI) on the 14-day chart is 32.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0808, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.69%. Stochastics %K at 19.84% indicates the stock is a buying.
How much short interest is there in Tempest Therapeutics Inc?
A steep rise in short interest was recorded in Tempest Therapeutics Inc stocks on 2024-10-31, growing by 0.78 million shares to a total of 2.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.86 million shares. There was a rise of 29.42%, which implies that there is a positive sentiment for the stock.
